(Q37991245)

26 August 2017

title

Pretargeting: taking an alternate route for localizing radionuclides (English)

1 reference

26 August 2017

Robert M Sharkey

1

1 reference

26 August 2017

Chien-Hsing Chang

2

1 reference

26 August 2017

Edmund A Rossi

3

1 reference

26 August 2017

William J McBride

4

1 reference

26 August 2017

David M Goldenberg

5

1 reference

26 August 2017

publication date

7 March 2012

1 reference

26 August 2017

number of pages

10

1 reference

inferred from page(s)

published in

Tumor Biology

1 reference

26 August 2017

volume

33

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

591-600

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-012-0367-6

26 August 2017

exact match

0 references

cites work

Monoclonal antibodies for medical oncology: a few critical perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Development trends for human monoclonal antibody therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Metrics for antibody therapeutics development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Targeted therapy of cancer: new prospects for antibodies and immunoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Cancer radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Clinical radioimmunotherapy--the role of radiobiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Phage library-derived human anti-TETA and anti-DOTA ScFv for pretargeting RIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Biodistribution and clearance of small molecule hapten chelates for pretargeted radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Optimization of hapten-peptide labeling for pretargeted immunoPET of bispecific antibody using generator-produced 68Ga.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

A novel method of 18F radiolabeling for PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Improved 18F labeling of peptides with a fluoride-aluminum-chelate complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

High-yielding aqueous 18F-labeling of peptides via Al18F chelation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Pretargeting of carcinoembryonic antigen-expressing cancers with a trivalent bispecific fusion protein produced in myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Multifunctional antibodies by the Dock-and-Lock method for improved cancer imaging and therapy by pretargeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Therapeutic advantage of pretargeted radioimmunotherapy using a recombinant bispecific antibody in a human colon cancer xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Renal dosimetry in peptide radionuclide receptor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Pretargeted 177Lu radioimmunotherapy of carcinoembryonic antigen-expressing human colonic tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

Antibodies against metal chelates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0367-6

The dock-and-lock method combines recombinant engineering with site-specific covalent conjugation to generate multifunctional structures

21 January 2018

1 reference

12 December 2020

Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten

1 reference

12 December 2020

Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates.

1 reference

12 December 2020

MIRD Pamphlet No 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney

1 reference

12 December 2020

An immunoenzymoassay for histamine

1 reference

12 December 2020

Bifunctional antibody: a binary radiopharmaceutical delivery system for imaging colorectal carcinoma

1 reference

12 December 2020

High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer

1 reference

12 December 2020

Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts

1 reference

12 December 2020

Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide.

1 reference

12 December 2020

Recognition of imidazole and histamine derivatives by monoclonal antibodies

1 reference

12 December 2020

Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial

1 reference

12 December 2020

Bivalent hapten-bearing peptides designed for iodine-131 pretargeted radioimmunotherapy

1 reference

12 December 2020

Two-step targeting and dosimetry for small cell lung cancer xenograft with anti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten

1 reference

12 December 2020

Pharmacokinetics and biodistribution of genetically-engineered antibodies

1 reference

12 December 2020

Pretargeting of carcinomas with the avidin-biotin system

1 reference

12 December 2020

A universal pretargeting system for cancer detection and therapy using bispecific antibody

1 reference

12 December 2020

In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate

1 reference

12 December 2020

Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy

1 reference

12 December 2020

Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial

1 reference

12 December 2020

Delivery of therapeutic doses of radioiodine using bispecific antibody-targeted bivalent haptens

1 reference

12 December 2020

Investigations of avidin and biotin for imaging applications

1 reference

12 December 2020

Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody

1 reference

12 December 2020

Therapy for colon carcinoma xenografts with bispecific antibody-targeted, iodine-131-labeled bivalent hapten

1 reference

12 December 2020

10.1007/S13277-012-0367-6

Identifiers

DOI

1 reference

26 August 2017

1 reference